Genentech: Home

News & Features

		Genentech Named Top Employer by Science Magazine On October 2, 2009, Genentech was named "top employer in the biopharmaceutical industry" by Science magazine. This is the seventh number one ranking for the company.



		Genentech Among the "Best Places to Work for LGBT Equality" in 2009 Genentech has received a 100 percent rating on the Human Rights Campaign (HRC) Foundation's Corporate Equality Index for the third consecutive year. Businesses that achieve a 100 percent are recognized by HRC as among the "Best Places to Work for LGBT Equality."

SCIENTIFIC LEADERSHIP >> Genentech's scientists are some of the most prolific in the industry and in their fields.



DEVELOPMENT PIPELINE >> Genentech's pipeline continues to grow, with more than 100 promising projects in development.

Genentech has issued a press release on Phase III studies of ACTEMRA® (tocilizumab) in rheumatoid arthritis.

View the April 14, 2009 press release announcing organizational and leadership decisions.

Related press releases and filings

Genentech has issued a Dear Healthcare Provider Letter for Rituxan® (rituximab) in rheumatoid arthritis.

Rituxan full prescribing information